Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fukutake

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Nippon Ganka Gakkai Zasshi|January 1, 1996
[Cytomegalovirus retinitis and Pneumocystis carinii choroidopathy in a patient with AIDS]N Usui, Y Yamauchi, H Minoda, et al.
AIDS (London, England)|September 4, 1998
Decline of anti-DP107 antibody associated with clinical progressionT Hattori, H Komoda, S Pahwa, et al.
Clinical and Diagnostic Virology|October 1, 1993
Phase I/II trial of didanosine (2',3'-dideoxyinosine) in hemophiliac patients with AIDS or AIDS-related complexK Yamada, S Kimura, M Negishi, et al.
Thrombosis and Haemostasis|May 1, 1997
Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopesH Suzuki, M Shima, M Arai, et al.
Journal of Human Virology|July 21, 1999
Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitorsW Sugiura, M Matsuda, Z Matsuda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 1998
[Prospective matched control study concerning the treatment and quality of life of hemophiliacs with inhibitors]K Honda, T Nagao, T Kamiya, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 20, 2012
Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd reportA Shirahata, K Fukutake, J Mimaya, et al.
International Journal of Hematology|August 16, 2001
Clinical trial to investigate the pharmacokinetics, pharmacodynamics, safety, and efficacy of recombinant factor VIIa in Japanese patients with hemophilia with inhibitorsA Shirahata, T Kamiya, J Takamatsu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 4, 2011
Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors--phase I trialA Shirahata, K Fukutake, J Mimaya, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 7, 2013
A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamicsA Shirahata, K Fukutake, J Takamatsu, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Nippon Ganka Gakkai Zasshi|January 1, 1996
[Cytomegalovirus retinitis and Pneumocystis carinii choroidopathy in a patient with AIDS]N Usui, Y Yamauchi, H Minoda, et al.
AIDS (London, England)|September 4, 1998
Decline of anti-DP107 antibody associated with clinical progressionT Hattori, H Komoda, S Pahwa, et al.
Clinical and Diagnostic Virology|October 1, 1993
Phase I/II trial of didanosine (2',3'-dideoxyinosine) in hemophiliac patients with AIDS or AIDS-related complexK Yamada, S Kimura, M Negishi, et al.
Thrombosis and Haemostasis|May 1, 1997
Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopesH Suzuki, M Shima, M Arai, et al.
Journal of Human Virology|July 21, 1999
Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitorsW Sugiura, M Matsuda, Z Matsuda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 1998
[Prospective matched control study concerning the treatment and quality of life of hemophiliacs with inhibitors]K Honda, T Nagao, T Kamiya, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 20, 2012
Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd reportA Shirahata, K Fukutake, J Mimaya, et al.
International Journal of Hematology|August 16, 2001
Clinical trial to investigate the pharmacokinetics, pharmacodynamics, safety, and efficacy of recombinant factor VIIa in Japanese patients with hemophilia with inhibitorsA Shirahata, T Kamiya, J Takamatsu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 4, 2011
Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors--phase I trialA Shirahata, K Fukutake, J Mimaya, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 7, 2013
A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamicsA Shirahata, K Fukutake, J Takamatsu, et al.
Pageof 16